Outsize U.S. bets delivered foreign investors years of windfall profits, but have left them exposed to this year’s reversal.

A European regulatory committee has rejected Eli Lilly’s U.S.-approved Alzheimer’s disease treatment over potentially ...

University of Michigan survey’s poorest result since 2022 reflects economic-policy anxiety.

Bank of America analysts on Friday said Novo Nordisk may miss first-quarter expectations, as sales of its blockbuster Wegovy ...

Lexicon Pharmaceuticals (LXRX) stock soars as the company inks a licensing deal worth up to $1B with Novo Nordisk (NVO) for ...

Kennedy Jr. was confirmed to lead the U.S. Department of Health and Human Services. United Statescategory US Securities and Exchange Commission beginning to onboard DOGE staff, email says 3:44 PM ...

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Novo Nordisk has defended disappointing trial results for its much-hyped next generation obesity drug candidate CagriSema, insisting it will be an “important” weight loss treatment.

WilmerHale joined Jenner & Block in suing to block the orders that strip their lawyers of security clearances and bar them from entering federal buildings. Skadden, a Top Law Firm, Seeks a Deal to ...

Fact checked by Nick Blackmer Compounded versions of semaglutide, the active ingredient in weight loss drugs like Ozempic and ...